Department of Orthopaedic Surgery, Hospital of Chung-Ang University of Medicine, Seoul, Republic of Korea.
Department of Orthopaedic Surgery, Hyundae General Hospital, Namyangju-si, Republic of Korea.
Arthroscopy. 2021 May;37(5):1641-1650. doi: 10.1016/j.arthro.2020.12.209. Epub 2020 Dec 24.
To determine whether arthroscopic transosseous foveal repair of the triangular fibrocartilage complex (TFCC) results in significant and clinically relevant improvement in clinical outcomes including pain and function with low complication and reoperation rates.
We reviewed studies investigating the clinical outcomes of arthroscopic transosseous foveal repair of the TFCC through MEDLINE, Embase, and the Cochrane Library. Studies on TFCC repair performed with an open or capsular technique and combined with other procedures, such as ulnar shortening osteotomy and a wafer procedure, were excluded. Methodologic quality was assessed using the Methodological Index for Non-randomized Studies score. Clinical outcomes were assessed using range of motion, grip strength, and patient-reported outcomes. Clinically relevant improvement was determined using the minimal clinically important difference (MCID).
A total of 443 unique studies were identified, of which 7 (131 patients) met the inclusion criteria. The mean age ranged from 27 to 37 years, and the mean follow-up period ranged from 23.5 to 31.1 months. The grip strength (as a percentage) increased after foveal repair of the TFCC in all studies (mean difference range, 11.8% to 22.3%). All studies also reported an improvement in the visual analog scale score (mean difference range, -9.8 to -1.88); Modified Mayo Wrist Score (mean difference range, 10.5 to 27); and Disabilities of the Arm, Shoulder and Hand score (mean difference range, -51.8 to -24.48). Considering clinically relevant improvements based on the MCID, 4 of 5 studies reporting the visual analog scale score showed improvements in this score (MCID, 2) and all studies reporting the Disabilities of the Arm, Shoulder and Hand score showed improvements in this score (MCID, 10). Most complications recovered without any treatment, and 3 patients (2.29%) needed a reoperation.
Arthroscopic transosseous foveal repair of the TFCC resulted in improvements in grip strength and functional outcomes with low complication and reoperation rates. However, the evidence for which technique produces better clinical outcomes remains limited.
Level IV, systematic review of Level III and IV studies.
确定关节镜下三角纤维软骨复合体(TFCC)窝状骨隧道修复术是否能显著改善临床结果,包括疼痛和功能,并具有较低的并发症和再次手术率。
我们通过 MEDLINE、Embase 和 Cochrane 图书馆检索了关节镜下 TFCC 窝状骨隧道修复术的临床结果研究。排除了采用开放式或囊内技术以及与尺骨缩短截骨和 wafer 手术等其他手术联合进行的 TFCC 修复研究。使用非随机研究方法学指数评估方法学质量。使用关节活动度、握力和患者报告的结果评估临床结果。使用最小临床重要差异(MCID)确定临床相关改善。
共确定了 443 项独特的研究,其中 7 项(131 例患者)符合纳入标准。平均年龄为 27 至 37 岁,平均随访时间为 23.5 至 31.1 个月。所有研究均报告 TFCC 窝状修复后握力(百分比)增加(平均差值范围为 11.8%至 22.3%)。所有研究还报告了视觉模拟评分(VAS)的改善(平均差值范围为-9.8 至-1.88);改良 Mayo 腕关节评分(MWHS)(平均差值范围为 10.5 至 27);和上肢残疾问卷(DASH)(平均差值范围为-51.8 至-24.48)。根据 MCID 考虑临床相关改善,5 项报告 VAS 评分的研究中有 4 项(MCID,2)显示出该评分的改善,所有报告 DASH 评分的研究均显示出该评分的改善(MCID,10)。大多数并发症未经治疗即可恢复,3 例患者(2.29%)需要再次手术。
关节镜下 TFCC 窝状骨隧道修复术可改善握力和功能结果,且并发症和再次手术率较低。然而,哪种技术能产生更好的临床结果的证据仍然有限。
IV 级,对 III 级和 IV 级研究的系统评价。